ATAI Life Sciences Eulerpool News

ATAI Life Sciences Eulerpool News

ATAI Life Sciences Stock News

ATAI Life Sciences is being monitored by journalists and investors worldwide. We gather the latest ATAI Life Sciences news here.

• June 26 ·

  Yahoo
  atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
• June 22 ·

  TalkMarkets
  Largest Clinical-Stage Biotech Drug Stocks Declined 6%
• June 20 ·

  Yahoo
  atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
• June 20 ·

  Thefly.com
  Atai Life Sciences announces update on Beckley's Phase 1/2a trial of ELE-101
• June 13 ·

  Thefly.com
  Here's What You Missed in Cannabis, Psychedelics This Week
• June 9 ·

  TalkMarkets
  Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
• June 5 ·

  SeekingAlpha
  Wall Street Lunch: Not An Ecstatic Day
• June 5 ·

  MarketWatch
  Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
• June 5 ·

  Seeking Alpha
  Biggest stock movers today: WKME, CRWD, HPE, and more
• June 5 ·

  Seeking Alpha
  Psychedelic stocks fall as FDA panel rejects MDMA therapy